Insider Buying: Pro Medicus (ASX:PME) Insider Purchases 2,080 Shares of Stock

Pro Medicus Limited (ASX:PME) insider Anthony Glenning purchased 2,080 shares of the business’s stock in a transaction that occurred on Friday, February 13th. The shares were purchased at an average price of A$119.81 per share, for a total transaction of A$249,204.80.

Pro Medicus Price Performance

The company has a market capitalization of $29.16 billion, a PE ratio of 351.99, a PEG ratio of 3.87 and a beta of 0.56. The company has a debt-to-equity ratio of 1.10, a quick ratio of 4.39 and a current ratio of 5.98.

Pro Medicus Dividend Announcement

The business also recently declared a Interim dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 19th will be issued a $0.32 dividend. The ex-dividend date is Wednesday, February 25th. This represents a dividend yield of 27.0%. Pro Medicus’s dividend payout ratio is presently 56.41%.

Pro Medicus Company Profile

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products.